Propionic Acidemia
A rare inherited disorder of propionate metabolism caused by PCCA or PCCB gene variants, which can lead to life-threatening metabolic crises without prompt diagnosis and ongoing specialist management.
- Newborn screening detectable
- Dietary protein management
- Specialist metabolic emergency planning
- Inheritance Pattern
- Autosomal Recessive
- Affected Genes
- PCCA / PCCB
- Detection
- Newborn Screening
- Advanced Therapies
- Liver Transplant, Gene Therapy Research
Condition Overview
Propionic acidemia is a rare inherited disorder caused by variants in the PCCA or PCCB genes, which together encode propionyl-CoA carboxylase, an enzyme needed to break down certain amino acids and fats. When this enzyme is deficient, propionic acid and related toxic metabolites accumulate in the body.
The condition typically presents in one of two ways: a severe neonatal-onset form, where infants become acutely unwell in the first days of life with poor feeding, lethargy, and metabolic crisis, or a milder late-onset form, where episodes of metabolic decompensation occur intermittently, often triggered by illness, fasting, or high protein intake.
Propionic acidemia is included in many newborn screening programs, allowing earlier identification. Management focuses on dietary protein restriction, prevention and rapid treatment of metabolic crises, and monitoring for long-term complications affecting the heart, nervous system, and other organs.
Types and Presentations
Propionic acidemia presentation is generally grouped by age of onset and severity.
Symptoms and Signs
Symptoms range from acute life-threatening metabolic crises in newborns to chronic, milder issues in later-onset disease.
Causes and Risk Factors
Propionic acidemia is caused by inherited enzyme deficiency, with metabolic crises typically triggered by additional physiological stress.
Diagnosis and Investigations
Diagnosis relies on biochemical organic acid testing, enzyme or genetic confirmation, and assessment of crisis-related complications.
Risk Stratification
Propionic acidemia is risk-stratified by severity of presentation and frequency of metabolic decompensation rather than a traditional staging system.
Standard Treatment Approach
Management combines dietary protein restriction, specific metabolic supplements, and a clear plan for managing illness to prevent and treat metabolic crises.
Advanced and Emerging Treatment Options
For severe or difficult-to-control disease, additional therapies beyond standard dietary management may be considered.
Surgical / Transplant
Liver transplantation
Considered in select patients with severe or poorly controlled disease, as the liver supplies much of the relevant enzyme activity and transplantation can reduce crisis frequency.
Metabolic Support
Carnitine and gut-targeted antibiotic therapy
Used to support carnitine status and reduce propionate production from gut bacteria.
Gene Therapy
Investigational gene and mRNA-based therapies
Early-phase research is exploring gene replacement and mRNA approaches aiming at restoring propionyl-CoA carboxylase activity.
Precision Medicine
Genotype-informed prognosis counseling
PCCA/PCCB variant type can help inform expected disease severity and family counseling.
Biomarkers and Precision Monitoring
Specific organic acid and acylcarnitine markers guide diagnosis and ongoing disease monitoring.
When a Second Opinion May Be Important
Given the complexity of propionic acidemia management, specialist second opinions can be valuable at key decision points.
Clinical Trials and Research
Prognosis and Key Outcome Factors
Outcomes in propionic acidemia vary widely depending on age at diagnosis, severity of initial presentation, and frequency of subsequent metabolic crises.
Supportive Care and Living With Propionic Acidemia
Day-to-day management requires coordinated dietary, medical, and emergency planning support.
How CancerFax Helps You Explore Treatment Options
CancerFax helps connect patients and families with metabolic specialists experienced in propionic acidemia and helps coordinate second opinions, including for liver transplant evaluation where appropriate.
Get a free case reviewFrequently Asked Questions
Propionic acidemia is a rare inherited disorder caused by PCCA or PCCB gene variants that impair the breakdown of certain amino acids and fats, leading to toxic buildup of propionic acid metabolites.
In severe cases, infants may show poor feeding, vomiting, and lethargy within days of birth. Milder cases may present later with recurrent illness episodes and developmental concerns.
Yes, it is included in many newborn screening programs through detection of elevated propionylcarnitine (C3).
Treatment includes a low-protein diet with specialized metabolic formula, carnitine supplementation, and a clear plan for managing illness to prevent metabolic crises.
Liver transplantation may be considered in select patients with severe or poorly controlled disease and is discussed individually with a transplant-experienced metabolic team.
Yes, cardiomyopathy is a recognized long-term complication, which is why regular cardiac monitoring is part of standard care.
Yes, it is inherited in an autosomal recessive pattern, caused by variants in the PCCA or PCCB genes.
Illness, fasting, and excess dietary protein intake are common triggers for metabolic decompensation.
Gene and mRNA-based therapies remain investigational and are being studied in clinical trials rather than offered as standard treatment.
Yes. CancerFax can help review your medical reports, coordinate a second opinion with metabolic specialists, and help identify centers experienced in managing propionic acidemia, including transplant evaluation and cross-border coordination where needed.
Managing Propionic Acidemia?
Get coordinated specialist support for metabolic management and crisis prevention.